| ORIGINAL ARTICLE |
|
| Year : 2017 | Volume
: 8
| Issue : 2 | Page : 49-53 |
|
|
Central line-associated bloodstream infection in pediatric oncology patients in Qatar: A prospective study
Tayseer Alsaad1, Mohamad Qaisuddin1, Doua AlSaad2, Prem Chandra3, Omar AlAbd2, Abdulla A Nasser1, Mohamad Janahi4, Anu Pilari5, Hisham Morsi6
1 Pediatric Hematology and Oncology Department, Hamad Medical Corporation, Doha, Qatar
2 Pharmacy Department, Hamad Medical Corporation, Doha, Qatar
3 Medical Research Center, Hamad Medical Corporation, Doha, Qatar
4 Pediatric Infectious Disease Department, Hamad Medical Corporation, Doha, Qatar
5 Nursing Department, Hamad Medical Corporation, Doha, Qatar
6 Pediatric Hematology and Oncology Department; Medical Research Center, Hamad Medical Corporation, Doha, Qatar
Correspondence Address:
Tayseer Alsaad
Pediatric Hematology and Oncology Department, Hamad Medical Corporation, P.O. Box 3050, Doha
Qatar
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/joah.joah_13_17
|
|
|
Objective: To assess the central line-associated bloodstream infection (CLABSI) rate and risk factors in hospitalized pediatric oncology patients in Qatar.
Materials and Methods: A prospective, observational study was conducted in pediatric oncology department at Hamad Medical Corporation, Qatar between January 1, 2013 and December 31, 2014. All children <14 years of age with malignancy who required a central line catheter were included.
Results: Thirty-seven subcutaneous tunneled catheters were inserted. Majority of the patients were younger than 10 years of age (88%), and the male-to-female ratio was 1.3:1. Leukemia was the most frequently encountered diagnosis. The overall mean central venous catheter (CVC) infection rate was 4.12 CLABSI per 1000 CVC days (95% confidence interval 2.41, 7.05). Thirteen catheters were infected (35.1%), of which 11 catheters were Porta-a-Cath, and two catheters were Hickman double lumen line. Gram-negative bacteria were found in 69.2% of the CLABSI cases, and no fungal infection was detected. Gender, age, type of disease, and type of catheter were not associated with increased risk for CLABSI (P > 0.05). The mean number of days with neutropenia was more in the patients who had CLABSI 73.5 ± 44.5 compared to the patients who did not have CLABSI 48.9 ± 52.1, but the difference did not reach statistical significance (P = 0.140).
Conclusion: The incidence rate of CLABSI continues to be a concern in hospitalized pediatric oncology patients in Qatar. This study showed that mean CVC infection rate was 4.12 CLABSI per 1000 CVC days. Gram-negative bacteria CLABSI were the dominant organism in this group of patients and catheters.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
